Translating Functional Connectivity After Stroke: Functional Magnetic Resonance Imaging Detects Comparable Network Changes in Mice and Humans.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
08 2021
Historique:
pubmed: 21 7 2021
medline: 6 1 2022
entrez: 20 7 2021
Statut: ppublish

Résumé

The translational roadblock has long impeded the implementation of experimental therapeutic approaches for stroke into clinical routine. Considerable interspecies differences, for example, in brain anatomy and function, render comparisons between rodents and humans tricky, especially concerning brain reorganization and recovery of function. We tested whether stroke-evoked changes in neural networks follow similar patterns in mice and patients using a systems-level perspective. We acquired resting-state functional magnetic resonance imaging data during the early poststroke phase in a sample of human patients and compared the observed network changes with data from 2 mouse stroke models, that is, photothrombosis and distal middle cerebral artery occlusion. Importantly, data were subjected to the same processing steps, allowing a direct comparison of global network changes using graph theory. We found that network parameters computed for both mouse models of stroke and humans follow a similar pattern in the postacute stroke phase. Parameters indicating the global communication structure’s facilitation, such as small worldness and characteristic path length, were similarly changed in humans and mice in the first days after stroke. Additionally, small worldness correlated with concurrent motor impairment in humans. Longitudinal observation in the subacute phase revealed a negative correlation between initial small worldness and motor recovery in mice. We show that network measures based on resting-state functional magnetic resonance imaging data after stroke obtained in mice and humans share notable features. The observed network alterations could serve as therapeutic readout parameters for future translational studies in stroke research.

Sections du résumé

Background and Purpose
The translational roadblock has long impeded the implementation of experimental therapeutic approaches for stroke into clinical routine. Considerable interspecies differences, for example, in brain anatomy and function, render comparisons between rodents and humans tricky, especially concerning brain reorganization and recovery of function. We tested whether stroke-evoked changes in neural networks follow similar patterns in mice and patients using a systems-level perspective.
Methods
We acquired resting-state functional magnetic resonance imaging data during the early poststroke phase in a sample of human patients and compared the observed network changes with data from 2 mouse stroke models, that is, photothrombosis and distal middle cerebral artery occlusion. Importantly, data were subjected to the same processing steps, allowing a direct comparison of global network changes using graph theory.
Results
We found that network parameters computed for both mouse models of stroke and humans follow a similar pattern in the postacute stroke phase. Parameters indicating the global communication structure’s facilitation, such as small worldness and characteristic path length, were similarly changed in humans and mice in the first days after stroke. Additionally, small worldness correlated with concurrent motor impairment in humans. Longitudinal observation in the subacute phase revealed a negative correlation between initial small worldness and motor recovery in mice.
Conclusions
We show that network measures based on resting-state functional magnetic resonance imaging data after stroke obtained in mice and humans share notable features. The observed network alterations could serve as therapeutic readout parameters for future translational studies in stroke research.

Identifiants

pubmed: 34281374
doi: 10.1161/STROKEAHA.120.032511
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2948-2960

Commentaires et corrections

Type : CommentIn

Auteurs

Stefan J Blaschke (SJ)

Faculty of Medicine and University Hospital, Department of Neurology, University of Cologne, Germany (S.J.B., L.H., S.V., C.T., S.U.V., M.R., M.S., G.R.F., C.G., M.A.R.).
In-Vivo NMR Laboratory, Max Planck Institute for Metabolism Research, Cologne, Germany (S.J.B., A.M., S.V., M.R., M.S., M.H., C.G., M.A.R.).
Cognitive Neuroscience Section, Institute of Neuroscience and Medicine (INM-3), Research Centre Juelich, Germany (S.J.B., L.H., C.T., M.S., G.R.F., M.H., C.G., M.A.R.).

Lukas Hensel (L)

Faculty of Medicine and University Hospital, Department of Neurology, University of Cologne, Germany (S.J.B., L.H., S.V., C.T., S.U.V., M.R., M.S., G.R.F., C.G., M.A.R.).
Cognitive Neuroscience Section, Institute of Neuroscience and Medicine (INM-3), Research Centre Juelich, Germany (S.J.B., L.H., C.T., M.S., G.R.F., M.H., C.G., M.A.R.).

Anuka Minassian (A)

In-Vivo NMR Laboratory, Max Planck Institute for Metabolism Research, Cologne, Germany (S.J.B., A.M., S.V., M.R., M.S., M.H., C.G., M.A.R.).

Susan Vlachakis (S)

Faculty of Medicine and University Hospital, Department of Neurology, University of Cologne, Germany (S.J.B., L.H., S.V., C.T., S.U.V., M.R., M.S., G.R.F., C.G., M.A.R.).
In-Vivo NMR Laboratory, Max Planck Institute for Metabolism Research, Cologne, Germany (S.J.B., A.M., S.V., M.R., M.S., M.H., C.G., M.A.R.).

Caroline Tscherpel (C)

Faculty of Medicine and University Hospital, Department of Neurology, University of Cologne, Germany (S.J.B., L.H., S.V., C.T., S.U.V., M.R., M.S., G.R.F., C.G., M.A.R.).
Cognitive Neuroscience Section, Institute of Neuroscience and Medicine (INM-3), Research Centre Juelich, Germany (S.J.B., L.H., C.T., M.S., G.R.F., M.H., C.G., M.A.R.).

Sabine U Vay (SU)

Faculty of Medicine and University Hospital, Department of Neurology, University of Cologne, Germany (S.J.B., L.H., S.V., C.T., S.U.V., M.R., M.S., G.R.F., C.G., M.A.R.).

Monika Rabenstein (M)

Faculty of Medicine and University Hospital, Department of Neurology, University of Cologne, Germany (S.J.B., L.H., S.V., C.T., S.U.V., M.R., M.S., G.R.F., C.G., M.A.R.).
In-Vivo NMR Laboratory, Max Planck Institute for Metabolism Research, Cologne, Germany (S.J.B., A.M., S.V., M.R., M.S., M.H., C.G., M.A.R.).

Michael Schroeter (M)

Faculty of Medicine and University Hospital, Department of Neurology, University of Cologne, Germany (S.J.B., L.H., S.V., C.T., S.U.V., M.R., M.S., G.R.F., C.G., M.A.R.).
In-Vivo NMR Laboratory, Max Planck Institute for Metabolism Research, Cologne, Germany (S.J.B., A.M., S.V., M.R., M.S., M.H., C.G., M.A.R.).
Cognitive Neuroscience Section, Institute of Neuroscience and Medicine (INM-3), Research Centre Juelich, Germany (S.J.B., L.H., C.T., M.S., G.R.F., M.H., C.G., M.A.R.).

Gereon R Fink (GR)

Faculty of Medicine and University Hospital, Department of Neurology, University of Cologne, Germany (S.J.B., L.H., S.V., C.T., S.U.V., M.R., M.S., G.R.F., C.G., M.A.R.).
Cognitive Neuroscience Section, Institute of Neuroscience and Medicine (INM-3), Research Centre Juelich, Germany (S.J.B., L.H., C.T., M.S., G.R.F., M.H., C.G., M.A.R.).

Mathias Hoehn (M)

Cognitive Neuroscience Section, Institute of Neuroscience and Medicine (INM-3), Research Centre Juelich, Germany (S.J.B., L.H., C.T., M.S., G.R.F., M.H., C.G., M.A.R.).

Christian Grefkes (C)

Faculty of Medicine and University Hospital, Department of Neurology, University of Cologne, Germany (S.J.B., L.H., S.V., C.T., S.U.V., M.R., M.S., G.R.F., C.G., M.A.R.).
In-Vivo NMR Laboratory, Max Planck Institute for Metabolism Research, Cologne, Germany (S.J.B., A.M., S.V., M.R., M.S., M.H., C.G., M.A.R.).
Cognitive Neuroscience Section, Institute of Neuroscience and Medicine (INM-3), Research Centre Juelich, Germany (S.J.B., L.H., C.T., M.S., G.R.F., M.H., C.G., M.A.R.).

Maria A Rueger (MA)

Faculty of Medicine and University Hospital, Department of Neurology, University of Cologne, Germany (S.J.B., L.H., S.V., C.T., S.U.V., M.R., M.S., G.R.F., C.G., M.A.R.).
In-Vivo NMR Laboratory, Max Planck Institute for Metabolism Research, Cologne, Germany (S.J.B., A.M., S.V., M.R., M.S., M.H., C.G., M.A.R.).
Cognitive Neuroscience Section, Institute of Neuroscience and Medicine (INM-3), Research Centre Juelich, Germany (S.J.B., L.H., C.T., M.S., G.R.F., M.H., C.G., M.A.R.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH